Claudia Vener

Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Laura Botta, Gemma Gatta, Riccardo Capocaccia et al. · The Lancet Oncology · 2022 · 186 citations · Full text

Medicine, Oncology, Pediatrics +17

Treatment of refractory chronic GVHD with rituximab: a GITMO study

Francesco Zaja, Andrea Bacigalupo, Francesca Patriarca et al. · Bone Marrow Transplantation · 2007 · 170 citations · Full text

Medicine, Immunology, Pharmacotherapy +6

The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis

Umberto Gianelli, Claudia Vener, Anna Bossi et al. · Modern Pathology · 2012 · 130 citations · Full text

Medicine, Hematology, Pathology +15

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Mauro Viganò, Claudia Vener, Pietro Lampertico et al. · Bone Marrow Transplantation · 2010 · 99 citations

Medicine, Hematology, Immunology +14

Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis

Claudia Vener, Nicola Stefano Fracchiolla, Umberto Gianelli et al. · Blood · 2007 · 85 citations · Full text

Medicine, Clinical Sciences, Pathology +17